Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Transarterial chemoembolization of advanced hepatocellular carcinoma: CT parameters for evaluating the response to therapy
Autore:
Vogl, TJ; Schroeder, H; Trapp, M; Straub, R; Schuster, A; Schuster, M; Mack, M; Souchon, F; Neuhaus, P;
Indirizzi:
Univ Frankfurt Klinikum, Inst Diagnost & Intervent Radiol, D-6000 Frankfurt, Germany Univ Frankfurt Klinikum Frankfurt Germany D-6000 6000 Frankfurt, Germany Humboldt Univ, Virchow Klinikum, Chirurg Klin, D-1086 Berlin, Germany Humboldt Univ Berlin Germany D-1086 Chirurg Klin, D-1086 Berlin, Germany
Titolo Testata:
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
fascicolo: 1, volume: 172, anno: 2000,
pagine: 43 - 50
SICI:
0936-6652(200001)172:1<43:TCOAHC>2.0.ZU;2-K
Fonte:
ISI
Lingua:
GER
Soggetto:
TRANSCATHETER ARTERIAL EMBOLIZATION; PROGNOSTIC FACTORS; PHASE-II; SURVIVAL; RESECTION; EFFICACY;
Keywords:
transarterial chemoembolization (TACE); hepatocellular carcinoma; computed tomography (CT);
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
29
Recensione:
Indirizzi per estratti:
Indirizzo: Vogl, TJ Univ Frankfurt, Inst Diagnost & Intervent Radiol, Theodor Stern Kai 7, D-63590 Frankfurt, Germany Univ Frankfurt Theodor Stern Kai 7 Frankfurt Germany D-63590 any
Citazione:
T.J. Vogl et al., "Transarterial chemoembolization of advanced hepatocellular carcinoma: CT parameters for evaluating the response to therapy", ROFO-F RONT, 172(1), 2000, pp. 43-50

Abstract

Purpose: An evaluation of clinical and computed tomography parameters for the transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). Material and Methods: Retro- and prospective analysis of 123 TACE procedures in 37 patients (mean age: 63.3 years). Results: Overall mean survival rate for all treated patients was 785 days with a mean value of 387 days. The 1 year survival rate was 62%. Quantitative tumor volumetry revealed a significant difference in survival rate with a mean value of 678 days for patients with a reduction of tumor volume between 0 and 50%, 976 days for a volume reduction of 51-100% and 277 days for an increase in tumor volume during therapy. Patients with a high lipiodol retention presented improved survival data (902 days) Versus patients with a low lipiodol retention (513 days). Homogeneous retention of lipiodol was a positive factor on survival as compared to an inhomogenous form of retention. Conclusion: In patients witha positive therapy response after TACE the prognosis can be improved by repeated embolization.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/12/20 alle ore 07:58:43